Cansortium Inc. (OTCMKTS:CNTMF – Get Rating) saw a significant increase in short interest in December. As of December 30th, there was short interest totalling 162,000 shares, an increase of 130.1% from the December 15th total of 70,400 shares. Based on an average trading volume of 461,700 shares, the short-interest ratio is currently 0.4 days.
Analysts Set New Price Targets
Separately, BTIG Research started coverage on Cansortium in a report on Friday, October 28th. They set a "buy" rating for the company.
Get Cansortium alerts:Cansortium Stock Performance
OTCMKTS CNTMF remained flat at $0.14 on Wednesday. The company's stock had a trading volume of 88,300 shares, compared to its average volume of 69,210. The stock's 50 day simple moving average is $0.15 and its two-hundred day simple moving average is $0.17. Cansortium has a 1-year low of $0.10 and a 1-year high of $0.68.
Cansortium Company Profile
(Get Rating)Cansortium Inc, through its subsidiaries, produces and sells medical cannabis in the United States. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. Cansortium Inc was incorporated in 2018 and is headquartered in Miami, Florida.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cansortium (CNTMF)
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.